Salvage radiotherapy for prostate cancer recurrence after surgery
Part of Cancer, Kidney & urinary clinical trials.
This study tests a very short course of radiation given after prostate surgery, specifically for men whose PSA is rising again. The goal is to see if this approach can safely control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man 18 or older
- You had surgery to remove your prostate
- Your PSA is between 0.1 and 2.0 ng/mL (a sign the cancer may be returning)
- A PSMA PET scan within 90 days shows no spread to lymph nodes or other parts of the body
- You never had radiation to the prostate or pelvis before, or brachytherapy
- You do not have active inflammatory bowel disease or take drugs that suppress your immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two schedules of pelvic radiotherapy for men whose prostate cancer has returned after surgery. Both schedules aim to control the cancer with fewer visits for one of them.
This study tests whether radiation therapy to the pelvis after prostate removal helps men whose cancer was found in nearby lymph nodes. The goal is to prevent cancer from coming back and improve survival.
This trial studies a targeted, high-intensity radiation approach given after prostate removal surgery when prostate cancer seems to be coming back locally. It may help control the disease in the pelvis while avoiding treatment that could cause more side effects.
This trial tests a type of focused radiation therapy for men with intermediate or high-risk prostate cancer that hasn't spread. It aims to improve outcomes by targeting the main tumor seen on MRI.
This study tests an “early salvage” approach using radiotherapy after prostate cancer surgery when PSA starts rising again. It aims to see whether earlier treatment (chosen based on higher-risk features) can improve outcomes for people who did not take immediate extra therapy after surgery.
This trial tests how well salvage radiation therapy works for prostate cancer that has come back after surgery. It looks at whether adding hormone therapy based on PSA response improves outcomes.
Hear when a new Prostate Cancer (Post Prostatectomy) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.